Taken together, the aforementioned findings demonstrated that silencing of lncRNA AGAP2-AS1 could enhance miR-195-5p expression, but down-regulate PDLIM5 expression, thereby deterring implanted tumor growth in vivo. This evidence concerns the gene AGAP2 and neoplasm.